Total Funding
56
60
Total FundingCorporate Round raised
Growth Score 56 in past quarter
-12 pts
Heat Score 60 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
12997
Nabsys is a life sciences company focused on the development of solid-state, single-molecule positional sequencing technology.
Acquired by 
Hitachi High-Tech
- Justin Bingham: Chief Commercial Officer
- Kevin DeGeeter: Chief Financial Officer
About the Company
Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic high-definition mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to
receive a “1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis.
It was founded in 2004 and headquartered in Providence, Rhode Island.


